Raphael Rapetti-Mauss

Raphael Rapetti-Mauss

Auto-generated profile, based on publicly available information

Raphael Rapetti-Mauss

Faculté des Sciences, Université Côte d’Azur, 06100 Nice, France

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2015 in Blood
Verified
Journal Article
Open access
PDF file
RRRaphael Rapetti-Mauss
Raphael Rapetti-Mauss
CLCaroline Lacoste
Caroline Lacoste
VPVéronique Picard
Véronique Picard
CGCorinne Guitton
Corinne Guitton
ELElise Lombard
Elise Lombard
CBCatherine Badens
Catherine Badens
The Gardos channel is a Ca2+-sensitive, intermediate conductance, potassium selective channel expressed in several tissues including erythrocytes and pancreas. In normal erythrocytes, it is involved in cell volume modification. Here, we report the identification of a dominantly inherited mutation in the Gardos channel in 2 unrelated families and its association with chronic hemolysis and dehydrated cells, also referred to as hereditary xerocytosis (HX). The affected individuals present chronic anemia that varies in severity. Their red cells exhibit a panel of various shape abnormalities such as elliptocytes, hemighosts, schizocytes, and very rare stomatocytic cells. The missense mutation concerns a highly conserved residue among species, located in the region interacting with Calmodulin and responsible for the channel opening and the K+ efflux. Using 2-microelectrode experiments on Xenopus oocytes and patch-clamp electrophysiology on HEK293 cells, we demonstrated that the mutated channel exhibits a higher activity and a higher Ca2+ sensitivity compared with the wild-type (WT) channel. The mutated channel remains sensitive to inhibition suggesting that treatment of this type of HX by a specific inhibitor of the Gardos channel could be considered. The identification of a KCNN4 mutation associated with chronic hemolysis constitutes the first report of a human disease caused by a defect of the Gardos channel.

23 January 2017 in Oncogene
Verified
Journal Article
Closed access
MGM Gueguinou
M Gueguinou
DCD Crottès
D Crottès
ACA Chantôme
A Chantôme
RRR Rapetti-Mauss
R Rapetti-Mauss
MPM Potier-Cartereau
M Potier-Cartereau
OSOlivier Soriani
Olivier Soriani

3 April 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RRRaphael Rapetti-Mauss
Raphael Rapetti-Mauss
VBViviana Bustos
Viviana Bustos
WTWarren Thomas
Warren Thomas
JMJean McBryan
Jean McBryan
HHHarry Harvey
Harry Harvey
BHBrian Harvey
Brian Harvey
Significance: The K + channel KCNQ1 has been proposed as a tumor suppressor in colorectal cancer (CRC), but nothing is known about its regulatory role in early disease stages. KCNQ1 is a target gene of Wnt/β-catenin, which is tonically activated in CRC. We demonstrate a bidirectional interaction between KCNQ1 and β-catenin as a key regulator of CRC cell differentiation, proliferation, and invasion. KCNQ1 stabilizes β-catenin at adherent junctions to maintain an epithelial phenotype. The β-catenin:T-cell factor (TCF)-4 transcriptional pathway directly represses KCNQ1 expression, and the loss of KCNQ1 was associated with an epithelial–mesenchymal transition. The KCNQ1:KCNE3 ion channel complex expression in primary tumors was correlated with good survival outcome for patients with CRC. KCNQ1 is a potential early prognostic biomarker for CRC.

1 August 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DCDavid Crottès
David Crottès
SMSonia MARTIAL
Sonia MARTIAL
RRRaphaël Rapetti-Mauss
Raphaël Rapetti-Mauss
Didier PisaniDidier Pisani
Didier Pisani
CLCéline Loriol
Céline Loriol
OSOlivier Soriani
Olivier Soriani
Sig1R (Sigma-1receptor) is a 25-kDa protein structurally unrelated to other mammalian proteins. Sig1R is present in brain, liver, and heart and is overexpressed in cancer cells. Studies using exogenous sigma ligands have shown that Sig1R interacts with a variety of ion channels, but its intrinsic function and mechanism of action remain unclear. The human ether-à-gogo related gene (hERG) encodes a cardiac channel that is also abnormally expressed in many primary human cancers, potentiating tumor progression through the modulation of extracellular matrix adhesive interactions. We show herein that sigma ligands inhibit hERG current density and cell adhesion to fibronectin in K562 myeloid leukemia cells. Heterologous expression in Xenopus oocytes demonstrates that Sig1R potentiates hERG current by stimulating channel subunit biosynthesis. Silencing Sig1R in leukemic K562 cells depresses hERG current density and cell adhesion to fibronectin by reducing hERG membrane expression. In K562 cells, Sig1R silencing does not modify hERG mRNA contents but reduces hERG mature form densities. In HEK cells expressing hERG and Sig1R, both proteins co-immunoprecipitate, demonstrating a physical association. Finally, Sig1R expression enhances both channel protein maturation and stability. Altogether, these results demonstrate for the first time that Sig1R controls ion channel expression through the regulation of subunit trafficking activity.

31 January 2016 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DCDavid Crottès
David Crottès
RRRaphael Rapetti-Mauss
Raphael Rapetti-Mauss
FAFrancisca Alcaraz-Pérez
Francisca Alcaraz-Pérez
MTMélanie Tichet
Mélanie Tichet
GGGiuseppina Gariano
Giuseppina Gariano
OSOlivier Soriani
Olivier Soriani
The sigma 1 receptor (Sig1R) is a stress-activated chaperone that regulates ion channels and is associated with pathologic conditions, such as stroke, neurodegenerative diseases, and addiction. Aberrant expression levels of ion channels and Sig1R have been detected in tumors and cancer cells, such as myeloid leukemia and colorectal cancer, but the link between ion channel regulation and Sig1R overexpression during malignancy has not been established. In this study, we found that Sig1R dynamically controls the membrane expression of the human voltage-dependent K+ channel human ether-à-go-go-related gene (hERG) in myeloid leukemia and colorectal cancer cell lines. Sig1R promoted the formation of hERG/β1-integrin signaling complexes upon extracellular matrix stimulation, triggering the activation of the PI3K/AKT pathway. Consequently, the presence of Sig1R in cancer cells increased motility and VEGF secretion. In vivo, Sig1R expression enhanced the aggressiveness of tumor cells by potentiating invasion and angiogenesis, leading to poor survival. Collectively, our findings highlight a novel function for Sig1R in mediating cross-talk between cancer cells and their microenvironment, thus driving oncogenesis by shaping cellular electrical activity in response to extracellular signals. Given the involvement of ion channels in promoting several hallmarks of cancer, our study also offers a potential strategy to therapeutically target ion channel function through Sig1R inhibition. Cancer Res; 76(3); 607–18. ©2015 AACR.

15 June 2017 in Haematologica
Verified
Journal Article
Closed access
PDF file
RRRaphaël Rapetti-Mauss
Raphaël Rapetti-Mauss
VPVéronique Picard
Véronique Picard
CGCorinne Guitton
Corinne Guitton
KGKhaldoun Ghazal
Khaldoun Ghazal
VPValérie Proulle
Valérie Proulle
HGHélène Guizouarn
Hélène Guizouarn
Recent advances have been made in the identification of molecular determinants of the rare hemolytic disease, dehydrated hereditary stomatocytosis (DHSt), also called hereditary xerocytosis (HX). This well-known red blood cell (RBC) pathology is characterized by an abnormal cation leak resulting in